CLINICAL_TRIALS
research
· 2014-01-10
Clinical Trial Update: Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer [Phase 3]
Summary
Phase 3 clinical trial update investigating whether selenium and vitamin E can prevent progression and recurrence of early-stage bladder cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Birmingham | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN